Accelerator-based epithermal neutron sources for boron neutron capture therapy of brain tumors

被引:0
|
作者
Blue, TE
Yanch, JC
机构
[1] Ohio State Univ, Dept Mech Engn, Nucl Engn Program, Columbus, OH 43210 USA
[2] MIT, Dept Nucl Engn, Cambridge, MA 02139 USA
[3] MIT, Whitaker Coll Hlth Sci & Technol, Cambridge, MA 02139 USA
关键词
accelerator; neutron; sources; BNCT;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper reviews the development of low- energy light ion accelerator- based neutron sources ( ABNSs) for the treatment of brain tumors through an intact scalp and skull using boron neutron capture therapy ( BNCT). A major advantage of an ABNS for BNCT over reactor- based neutron sources is the potential for siting within a hospital. Consequently, light- ion accelerators that are injectors to larger machines in high- energy physics facilities are not considered. An ABNS for BNCT is composed of: ( 1) the accelerator hardware for producing a high current charged particle beam, ( 2) an appropriate neutron- producing target and target heat removal system ( HRS), and ( 3) a moderator/ reflector assembly to render the flux energy spectrum of neutrons produced in the target suitable for patient irradiation. As a consequence of the efforts of researchers throughout the world, progress has been made on the design, manufacture, and testing of these three major components. Although an ABNS facility has not yet been built that has optimally assembled these three components, the feasibility of clinically useful ABNSs has been clearly established. Both electrostatic and radio frequency linear accelerators of reasonable cost (similar to $ 1.5 M) appear to be capable of producing charged particle beams, with combinations of accelerated particle energy ( a few MeV) and beam currents (similar to 10 mA) that are suitable for a hospital- based ABNS for BNCT. The specific accelerator performance requirements depend upon the charged particle reaction by which neutrons are produced in the target and the clinical requirements for neutron field quality and intensity. The accelerator performance requirements are more demanding for beryllium than for lithium as a target. However, beryllium targets are more easily cooled. The accelerator performance requirements are also more demanding for greater neutron field quality and intensity. Target HRSs that are based on submerged- jet impingement and the use of microchannels have emerged as viable target cooling options. Neutron fields for reactor- based neutron sources provide an obvious basis of comparison for ABNS field quality. This paper compares Monte Carlo calculations of neutron field quality for an ABNS and an idealized standard reactor neutron field ( ISRNF). The comparison shows that with lithium as a target, an ABNS can create a neutron field with a field quality that is significantly better ( by a factor of similar to 1.2, as judged by the relative biological effectiveness ( RBE)- dose that can be delivered to a tumor at a depth of 6 cm) than that for the ISRNF. Also, for a beam current of 10 mA, the treatment time is calculated to be reasonable (similar to 30 min) for the boron concentrations that have been assumed.
引用
收藏
页码:19 / 31
页数:13
相关论文
共 50 条
  • [31] CONCEPTUAL DESIGN OF AN RFQ ACCELERATOR-BASED NEUTRON SOURCE FOR BORON NEUTRON-CAPTURE THERAPY
    WANGLER, TP
    STOVALL, JE
    BHATIA, TS
    WANG, CK
    BLUE, TE
    GAHBAUER, RA
    PROCEEDINGS OF THE 1989 IEEE PARTICLE ACCELERATOR CONFERENCE, VOLS 1-3: ACCELERATOR SCIENCE AND TECHNOLOGY, 1989, : 678 - 680
  • [32] Development and application of neutron field optimization parameters for an accelerator-based neutron source for boron neutron capture therapy
    Woollard, JE
    Blue, TE
    Gupta, N
    Gahbauer, RA
    NUCLEAR TECHNOLOGY, 1996, 115 (01) : 100 - 113
  • [33] In Vivo Accelerator-Based Boron Neutron Capture Therapy for Spontaneous Tumors in Large Animals: Case Series
    Kanygin, Vladimir
    Kichigin, Aleksandr
    Zaboronok, Alexander
    Kasatova, Anna
    Petrova, Elena
    Tsygankova, Alphiya
    Zavjalov, Evgenii
    Mathis, Bryan J.
    Taskaev, Sergey
    BIOLOGY-BASEL, 2022, 11 (01):
  • [34] Accelerator-based boron neutron capture therapy facility at the Helsinki University Hospital
    Porra, Liisa
    Seppala, Tiina
    Wendland, Lauri
    Revitzer, Hannu
    Joensuu, Heikki
    Eide, Paul
    Koivunoro, Hanna
    Smick, Noah
    Smick, Theodore
    Tenhunen, Mikko
    ACTA ONCOLOGICA, 2022, 61 (02) : 269 - 273
  • [35] Experimental verification of in-phantom calculations for an accelerator-based neutron source for boron neutron capture therapy
    Dobelbower, MC
    Vest, A
    Reed, MJ
    Blue, TE
    MEDICAL PHYSICS, 1999, 26 (03) : 376 - 380
  • [36] A NEUTRONIC STUDY OF AN ACCELERATOR-BASED NEUTRON-IRRADIATION FACILITY FOR BORON NEUTRON-CAPTURE THERAPY
    WANG, CKC
    BLUE, TE
    GAHBAUER, R
    NUCLEAR TECHNOLOGY, 1989, 84 (01) : 93 - 107
  • [37] A study on out-of-field leakage of an accelerator-based neutron beam for boron neutron capture therapy
    You, Zhen-Fan
    Huang, Chun-Kai
    Liu, Yen-Wan Hsueh
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [38] Boron neutron capture therapy in the new age of accelerator-based neutron production and preliminary progress in Canada
    Dziura, Dominik
    Tabbassum, Sana
    MacNeil, Amanda
    Maharaj, Dalini D.
    Laxdal, Robert
    Kester, Oliver
    Pan, Ming
    Kumada, Hiroaki
    Marquardt, Drew
    CANADIAN JOURNAL OF PHYSICS, 2023, 101 (08) : 363 - 372
  • [39] Development of an online neutron beam monitoring system for accelerator-based boron neutron capture therapy in a hospital
    Takada, Masashi
    Yagi, Natsumi
    Nakamura, Satoshi
    Shimada, Kenzi
    Itami, Jyun
    Igaki, Hiroshi
    Nakamura, Masaru
    Nunomiya, Tomoya
    Endo, Satoru
    Kajimoto, Tsuyoshi
    Tanaka, Kenichi
    Aoyama, Kei
    Narita, Masakuni
    Nakamura, Takashi
    MEDICAL PHYSICS, 2024,
  • [40] Performance verification of an epithermal neutron flux monitor using accelerator-based BNCT neutron sources
    Guan, X.
    Murata, I.
    Wang, T.
    JOURNAL OF INSTRUMENTATION, 2017, 12